Mortality in Patients Admitted for Concurrent COPD Exacerbation and Pneumonia

Area of Science:

• Pulmonary Medicine
• Critical Care Medicine
• Epidemiology

Background:

• Concurrent pneumonia and chronic obstructive pulmonary disease (COPD) present a complex clinical challenge.
• The differential impact of these conditions, individually and combined, on mortality outcomes remains incompletely understood.

Purpose of the Study:

• To investigate the comparative effects of pneumonia alone, COPD exacerbation alone, and concurrent pneumonia with COPD on inpatient, 30-day, and overall mortality.
• To analyze how the interaction between pneumonia and COPD influences mortality patterns over time.

Main Methods:

• Retrospective cohort study utilizing a Veterans Health Affairs database.
• Inclusion of 15,065 patients categorized into three primary discharge diagnosis groups: COPD exacerbation without pneumonia (AECOPD), pneumonia without COPD (PNA), and pneumonia with concurrent COPD (PCOPD).
• Comparison of inpatient, 30-day, and overall mortality rates across the three cohorts, with a median follow-up of 37 months.

Main Results:

• A stepwise increase in inpatient mortality was observed: AECOPD (4.8%), PNA (9.5%), and PCOPD (13.2%).
• These mortality differences persisted at 30 days post-discharge (AECOPD 6.7%, PNA 12.4%, PCOPD 14.6%).
• Over the study period, the death rate increased disproportionally in the AECOPD group (64.5%), while PCOPD predicted the greatest inpatient mortality (p < 0.001).

Conclusions:

• The combination of pneumonia and COPD (PCOPD) demonstrates a significantly higher inpatient and 30-day mortality compared to either condition alone.
• Pneumonia primarily impacts inpatient and 30-day mortality, whereas COPD has a more pronounced effect on overall, long-term mortality.
• Findings highlight the distinct and cumulative risks associated with concurrent pneumonia and COPD, informing clinical management and prognosis.